MGC Pharma

APRIL 4, 2018

A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals. CBD-based treatment for people with Refractory Epilepsy?—?is Refractory Epilepsy is epilepsy that involves frequent and severe seizures that are difficult to treat. CannEpil™?—?CBD-based

Epilepsy 100

Epilepsy Pharmaceutical Research and Development CBD 100

SpeedWeed

MARCH 30, 2021

THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. An estimated 250 patients a month are said to be prescribed cannabis medicines through the NHS compared to over 2,500 in the UK’s private sector. Step In Right Direction.

Data 52

Data Patients Clinical Trials Business 52

NORML

MAY 24, 2019

Legislation that would have significantly expanded patient access to medical cannabis in Rhode Island was held in a senate committee for further study, ultimately killing the bill. Legislation is pending, Senate Bill 236, to allow qualifying patients with certain debilitating conditions to use and safely access medical cannabis.

Legislation 193

Legislation Hemp Access Patients 193

CannaTech

JUNE 30, 2019

These include changes to reduce barriers to patient access, specific licensing requirements for production, and expanding the number of access points approved of sale. The main goal of the reform is to ease bureaucratic hurdles for patients and to improve the quality and consistency of medical cannabis. Severe epilepsy in minors.

Patients 90

Patients Oil Epilepsy Strains 90

MGC Pharma

DECEMBER 12, 2017

Fortunately, at MGC Pharma, we are in the business of Medical Cannabis and have spent years researching and understanding the effects and phenotypes of different strains to determine which ones work best for different conditions, with each containing different amounts of THC, CBD and other components. You can learn more about that here.

Epilepsy 100

Epilepsy Pharmaceutical Cannabinoids THC 100

Cannabis Law Report

JULY 27, 2021

and its Scientific Advisory Board, the Organization Publishes New Real-World Study on Epilepsy and CBD. –(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoid research, has appointed Nicolas Schlienz, Ph.D., Under the Leadership of Nicolas Schlienz, Ph.D., COLORADO SPRINGS, Colo.–(BUSINESS

Data 81

Data Epilepsy Research and Development Clinical Trials 81

Cannabis Law Report

SEPTEMBER 29, 2022

Australia’s drugs regulator issues 73 infringement notices over claims prescriptions could treat conditions such as cancer and epilepsy. It is also alleged that the unlawful advertising included unapproved references to the treatment of serious diseases or conditions, including in some cases cancer and epilepsy.

Epilepsy 52

Epilepsy Conditions Media Medicine 52

MMJ Recs

MAY 10, 2022

And the best news is that attending a patient drive in Utah can make this process much simpler! Read on to learn all you need to know about patient drives in Utah. Image by Craventure Media on Unsplash : what is an MMJ patient drive in UT? What is a Utah patient drive? How does a Utah patient drive work?

Patients 52

Patients Dispensary Events Chronic Pain 52

Veriheal

SEPTEMBER 22, 2021

If the proposal — which was sponsored by Rules Committee Chairman Bill Rabon (R) — is enacted into law, patients who are diagnosed with a “debilitating medical condition” could legally gain access to medical cannabis in North Carolina. Home cannabis cultivation, on the other hand, would be forbidden. by 2024.

Legalization 124

Legalization Patients Cultivation Legislation 124

MMJ Recs

MAY 5, 2022

In some cases, this can be done through a Louisiana patient drive. Read on to learn all you need to know about MMJ certification and patient drives in Louisiana. Image by João Francisco on Unsplash : How do you set up an MMJ patient drive in Louisiana? What is a Louisiana patient drive?

Patients 52

Patients Dispensary Conditions Access 52

MMJ Recs

MAY 15, 2022

This initial MMJ legislation only allowed patients suffering from intractable epilepsy to use cannabis oil. In 2020, the law changed to allow patients with any medical condition to receive a doctor’s recommendation to use and purchase medical marijuana products containing a maximum 10 milligrams of THC.

Patients 52

Patients Marijuana Pharmaceutical Dispensary 52

MMJ Recs

APRIL 30, 2022

Getting access to medical marijuana in the state of Virginia requires patients to complete a few different steps in the application process. In some cases, there are events known as patient drives that can make the process even easier for qualifying individuals to get their recommendation and access medical marijuana.

Patients 52

Patients Dispensary Chronic Pain Access 52

MMJ Recs

MARCH 25, 2022

Image by msqrd2 on Pixabay : Looking for more information on patient drives in New York? The application process for a New York MMJ card typically involves the following steps: First, register with MMJRecs and create a patient login, providing some basic information and answering a short and simple questionnaire.

Patients 52

Patients Conditions Chronic Pain Dispensary 52

MMJ Recs

APRIL 15, 2022

The following conditions qualify for a Missouri MMJ card: Alzheimer’s disease Autism Cancer Crohn’s disease Chronic pain Epilepsy Glaucoma Hepatitis C HIV/AIDS Huntington’s disease IBS Intractable migraines Lou Gehrig’s disease Multiple sclerosis Opioid substitution Parkinson’s disease. What is a MO patient drive? Keep reading!

Patients 52

Patients Chronic Pain Conditions Dispensary 52

MMJ Recs

MARCH 30, 2022

Pennsylvania voted to legalize medical marijuana in 2016, and Pennsylvania dispensaries opened for business at the beginning of 2018. There are now 198 MMJ dispensaries open for business in the state. Recently, patient drives in Pennsylvania have made MMJ cards accessible to a lot of PA residents. Patient Drives In Pennsylvania.

Patients 52

Patients Dispensary Events Treatment 52

Cannabis Law Report

SEPTEMBER 28, 2021

DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Insight, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. This Epilepsy – Pipeline Insight, 2021 provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Epilepsy pipeline landscape.

Epilepsy 40

Epilepsy Clinical Trials Research and Development Pharmaceutical 40

Otherside Farms

DECEMBER 21, 2019

Are you considering getting into the growing and/or selling business and want to know how to promote your products to your customers? For cancer patients who are undergoing chemotherapy, medical marijuana can be a lifesaver. It can help to reduce the amount of nausea that patients may feel after chemotherapy treatments.

Digestion 96

Digestion Marijuana Indica Epilepsy 96

MGC Pharma

FEBRUARY 15, 2018

A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals Right now in Australia, access to Cannabis-based treatments is heavily restricted. Physicians who want to prescribe Medicinal Cannabis are required to jump through countless regulatory hoops, as are patients seeking treatment.

Access 100

Access Medicine Chronic Pain Research and Development 100

MMJ Recs

NOVEMBER 17, 2023

This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. New businesses have emerged, and existing companies have expanded to support the industry’s various needs.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

CannaTech

APRIL 1, 2020

In practical terms, we studied how pharmaceuticals interact, how to accurately measure and dispense medications, advise patients on effective protocols and adverse events, what to do and not to do when using specific medications. Over 60,000 patients in Israel receive medical cannabis through pharmacies and distributors.

Supply Chain 98

Supply Chain Chronic Pain Pharmaceutical Patients 98

MassRoots

MARCH 7, 2019

House Bill 136 was overwhelmingly approved in a vote of 16 to one after committee members heard from constituents who suffer from health problems such as epilepsy and chronic pain. Patient Testimony. There will be a small excise tax associated with each transaction to cover the cost of program regulation and the indigent patient fund.

Chronic Pain 91

Chronic Pain Epilepsy Legislation Patients 91

Veriheal

AUGUST 25, 2021

The state recently awarded cultivation licenses to six growers, all of whom are expected to launch their businesses in the next few months. However, rejected applicants, medical marijuana advocates and patients are voicing their concerns over the controversial decision-making process. . 21 Companies File Protests Following Rejection .

Cultivation 98

Cultivation Oil THC Patients 98

MMJ Recs

AUGUST 29, 2022

The first MMJ dispensaries in Missouri opened for business in 2020, and since then, the MO dispensaries list has quickly grown from a small handful to almost 200. Missouri dispensaries are now selling high-quality, locally produced marijuana products to hundreds of thousands of Missouri MMJ patients.

Dispensary 52

Dispensary Patients Treatment Education 52

Cannabis Info

OCTOBER 11, 2019

European Cannabis Business News and Updates for This Week. With 19 licensed importers in Germany in the meanwhile, this represents an necessary time within the development of the nation’s medical cannabis business. Epidiolex is an epilepsy-fighting cannabis base drug produced by GW Prescription drugs.

Business 45

Business Epilepsy Clinical Trials Treatment 45

Cannabis Law Report

NOVEMBER 17, 2021

This National Epilepsy Awareness Month, TXOG advocates for the power of medical cannabis for epilepsy patients. ACT highlights Texans who have found relief and comfort through TXOG’s medicine—patients like Jacob Ortiz, a 7-year-old who has achieved one year without a seizure as a result of TXOG’s medical cannabis.

Patients 40

Patients Epilepsy Medicine Advocacy 40

CannaTech

JUNE 30, 2019

Changes to Israeli medical cannabis regulation by the Ministry of Health’s Medical Cannabis Association, locally known as Yakar, have left vulnerable patients with reduced access and increasing cots. Although changes were intended to reduce barriers to patient access, this has not been the case. Severe epilepsy in minors.

Patients 40

Patients Oil Epilepsy Strains 40

Cannabis Law Report

DECEMBER 3, 2021

–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. An analysis from continuous EEG recordings in 17 patients enrolled in the Phase 2 refractory status epilepticus (RSE) study demonstrated a substantial increase in the alpha/delta ratio immediately after the start of IV ganaxolone in 75% of patients.

Epilepsy 40

Epilepsy Pharmaceutical Data Clinical Trials 40

The Cannigma

APRIL 5, 2021

The state still needs to staff the Office of Cannabis Management and the Cannabis Control Board, finalize the regulations for cannabis sellers, producters, and growers, and approve licenses for cannabis businesses. The rules for medical patients will be different. Amsterdam-style coffee shops. The good news?

Legalization 137

Legalization Consumption Dispensary Vaping 137

MMJ Recs

OCTOBER 2, 2023

California has been a trailblazer in the realm of medical marijuana, offering patients access to a variety of treatment options. Patients must first schedule an appointment with a licensed medical professional who can evaluate their medical history and condition. In 1996, the state became the first in the U.S.

Dispensary 52

Dispensary Patients Environment Conditions 52

MGC Pharma

FEBRUARY 20, 2018

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

NORML

MAY 1, 2019

” Read more from Crain’s Chicago Business ! David Phipps, communications director of Indiana Norml, said CBD oil can help with epilepsy, noting cases where some child patients went from over 100 seizures a day to near zero when they started taking CBD.” . “Allowing people to grow cannabis at home.

Decriminalization 194

Decriminalization Seed-To-Sale Marijuana Patients 194

Cannabis Law Report

AUGUST 17, 2021

reduction in 28-day seizure frequency relative to baseline in tuberous sclerosis complex (TSC) patients (n=23). reduction was observed in focal seizures (n=19), the most common seizure type in TSC patients. Phase 3 planning for TrustTSC trial ongoing with first patient expected to be enrolled in Q4 2021. RADNOR, Pa.–(BUSINESS

Pharmaceutical 76

Pharmaceutical Clinical Trials Treatment Patients 76

CannaEffect

JULY 7, 2017

Harper Howard’s family never saw her smile until age 3, when they administered hemp oil to treat the life-threatening genetic disorder CDKL5 epilepsy. Lily Howard, making history as one of the youngest guests to ever appear on Cannabis Talk 101, said “My sister Harper was born when I was 2.

Business 57

Business Oil Hemp Epilepsy 57

Cannabis Law Report

SEPTEMBER 20, 2021

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. Nanomerics”) to use Nanomeric’s molecular envelope platform technology (MET) for the nasal delivery of a cannabidiol (CBD) for the management of epilepsy in adults and children. VRP324 is manufactured using high pressure homogenization and spray drying.

Epilepsy 40

Epilepsy Research and Development Clinical Trials Chronic Pain 40

Veriheal

NOVEMBER 10, 2020

The experiment consists of a two-year cycle where up to 3,000 patients will be treated with medical cannabis. In an interview with Marijuana Business Daily , Nicolas Authier explained that since cannabis with higher quantities of THC is illegal, most of the cannabis supplies will probably come from foreigners for the sake of the experiment.

Chronic Pain 90

Chronic Pain Pharmaceutical Patients Epilepsy 90

Cannabis Law Report

DECEMBER 9, 2021

A 4-year-old Texas Original Compassionate Cultivation patient improves seizure control, behaviors and sleep with the company’s medicine. Early in childhood, Carter was diagnosed with Lennox-Gastaut syndrome (LGS), an uncommon form of childhood epilepsy. About Texas Original Compassionate Cultivation.

Conditions 40

Conditions Patients Sleep Medicine 40

Cannabis Law Report

AUGUST 19, 2021

– ‘No definitive evidence’ – British charity Versus Arthritis recommends patients contemplating CBD should consult their doctor beforehand, and also wants more work done to understand its impact. LDN CBD launched in 2018 to tap into the new market, and is seeking a new round of financing to fund expansion.

Cannabinoids 105

Cannabinoids Seed-To-Sale Clinical Trials CBD 105